Additional Resource for the IU Clinical Research Network

Slides:



Advertisements
Similar presentations
Award Appropriation 101: Dollars and Sense Stephanie Logaras Associate Grants Officer Office for Sponsored Research Andrew Mark Grants Assistant Office.
Advertisements

USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.
USC Clinical Trials Office (CTO) Submitting your Studies to CTO For Processing Soheil Jadali Director, Clinical Trial Office.
Clinical Trials Budgeting, Part 2. Agenda Overview of clinical trials fund setup by OSP/OSPA Invoicing for study start-up fees Invoicing for per patient/milestone.
Research Study Initiation Process GRU CLINICAL AND TRANSLATIONAL RESEARCH LABORATORY RESEARCH ANIMAL RESEARCH HUMAN RESEARCH GRU Clinical.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Office of Research Administration Update Jim Becker OVPRA CATS Session January 21, 2009.
Working with DSP (main phone) Wendy Beaver Diana Boeglin Jessica Boyle Erin Brothers Pat Cone-Fisher Caite Flaherty.
November 10, Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Patricia.
Determining % Effort for Clinical Trial Kathy Price, RN, MBA Manager, GI Clinical Research.
Annual Certifications 1. Completing an Annual Certification Form The purpose of the Annual Certification is to ensure that faculty have reported all of.
Office of Grants & Contracts Accounting (OGCA) Financial Status Reporting (FSR) & Final Invoices using the Award Reconciliation & Review Tool (ARRT) 1.
PreAward Training January 30 th, 2015 Presented by: Maria Rojas & Dr. Helena Solo-Gabriele.
Online Data Management System: Navigating the ACRIN Website Page 1.
Driving Innovation to Market. Partnering with the Office of Intellectual Property and Industry Sponsored Research December 10, 2013 Tara A. Kamin, Esq.
CONFLICTS OF INTEREST PRESENTED BY THE UMMC OFFICE OF INTEGRITY AND COMPLIANCE.
1 WUSM RA Forum September 2006 Grants & Contracts.
Budget Development Presented by: Jean Mercer Associate Director for Clinical Research Administration Office of Clinical Research – School of Medicine.
Tips on Routing and Contracts: An Intro for the Campus Research Coordinator Michelle Artmeier Director of Award Services Ron.
New SPO Website SPO has launched a new website! It has a new look and feel Follows the Sponsored Research Life Cycle It is tied to the SPO Wiki so SPO.
LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.
JCRI Business Operations – Post-Award. Processes relating to the collection of sponsored clinical trial funding.
Business Operations Pre-Award. What is required to begin the business process? Possible indicators CDA executed Cancer Center MDG/PRC approvals Department.
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
The Business Operations of Clinical Research Trials, From Start to Finish.
CLINICAL RESEARCH STUDIES Business & Finance (B &F) Prospective Patricia W. Davis Director of Research Office of Business & Finance
Slide 1 Outgoing Subawards Financial Process Tips.
Using A Central IRB At Thomas Jefferson University / Hospital Roseann Talarico Associate Director Office of Human Research.
IU-CLINICAL TRIALS OFFICE A. Marisa King, MBA, MA, LMHC Clinical Research Contract Officer 1IU-CTO RCEP 19OCT15.
May 5, 2016 Working With CTO Contracting: How Do I Get My Clinical Trial Contract Negotiated & Why Isn’t It Signed Yet? Jaci Brown, Manager, CTO-Contracting.
Business Operations Pre-Award. Confidential Disclosure Agreements (CDA)/ Non-Disclosure Agreements (NDA)
Submitting to a Commercial IRB Kyle Conner, MA, CIP Associate Director Office of Human Research.
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Research Approval Workflow EPIC Optimization
Submitting a New IRB Protocol
Award Set-Up and Advances
Research Master ID (RMID)
Study Feasibility and Start-up
Submitting a New IRB Protocol
Clinical Trial Budgeting
Investigator of Record – Definition
What’s Changing in Research Administration?
Introduction to Sponsored Programs
Introduction to Clinical Trials: Documents and Processes
Office of Research Administration: Clinical Research Contracting
Clinical Trial Contracts Office -What’s the Hold Up?
ESTR Basics for View-Only Users
Introduction to Sponsored Programs
For investigators planning to conduct human participant research
KC IRB Implementation – Phase IV
Outgoing Subs Understanding Subawards and Subcontracts
Agreements OSR Symposium
Industry Funded Research - Process for Contracts
Research Master ID (RMID)
Top Ten eIRB Application Mistakes
Clinical Trials at USC – Who handles budgeting and contracting?
Subrecipient vs. Contractor Determinations
What is a Proposal & How do I get started?
SUNY Pre Award and Compliance Systems Institutional Review Board (IRB)
Getting a Study Done at Jefferson:
Budget Overhaul Presented by:
Clinical Trials Budgeting, Part 2
Investigator of Record – Definition
Investigator of Record – Definition
Submitting a New IRB Protocol
Post-Award Grant Administration
Presented by Trevor Johnson OCGA
Change to Commercial IRB Fees
CU Medicine/University Contract Routing T. K
Office of Grants and Contracts Presenter: Stephanie Chandler-Thompson
Presentation transcript:

Additional Resource for the IU Clinical Research Network

Questions?

IU-CTO – Kuali Coeus Proposal Routings Logic Update Proposal Guidance Supplemental Guidance Reminders

IU –CTO – Kuali Coeus Proposal Routing Logic Update Ability to route proposals to the IU-CTO where the main sponsor is a non-profit entity but the prime sponsor (funding source) is a commercial sponsor EXAMPLE 1: University pass through (i.e. Sponsor = UCLA [non-profit entity], prime sponsor = Eli Lilly [commercial sponsor], and “clinical trials” box checked) EXAMPLE 2: Consortium Study (i.e. Sponsor = HCRN, prime sponsor = Eli Lilly, and “clinical trials” box checked) Screen Shot:

IU-CTO – Kuali Coeus Proposal Guidance The IU-CTO, in conjunction with ORA, has recently updated the Kuali Coeus Proposal Training Guide for routing Commercial Clinical Trials . The guidance has been posted in the Kuali Coeus training site at the following link: http://researchadmin.iu.edu/EO/eo_kc_grants.html This guide will be posted to the new IU-CTO website on the Additional Resources Page

Important Reminders: To route a proposal to the IU-CTO, always click the “clinical trials” box For new CTA, activity type will always be “service/other” For CTA Amendments the proposal type will always be either: “revision/supplemental” (if there are supplemental funds associated with the Amendment) OR “revision/other” (if there are NO supplemental funds associated with the Amendment) For proposal types “new” or “revision/supplemental” please make sure the budget versions tab is complete and an internal budget is attached to your proposal

IU-CTO – Kuali Coeus Proposal Supplemental Guidance The IU-CTO has recently created a supplemental guidance for Kuali Coeus Proposals to outline what types of proposals get routed to the IU-CTO and what types of proposals get routed to ORA

CTO No ORA Yes No Human Subjects ORA Yes No Prospective ORA Yes [Direct or Pass-through] ORA Yes Human Subjects No ORA Yes No Prospective ORA E.g. Retroactive chart reviews Yes Interventional Observational Epidemiologic No ORA E.g. Ex vivo studies (assay development) Yes No Per Patient Budget ORA E.g. Fee for Service Yes CTO E.g. Fixed price based on CRF’s or milestones or Sponsor provides study drug or device at no cost.

The flow chart begins with the funding source The flow chart begins with the funding source. The first check is if the funding source is directly from a commercial sponsor or a pass through a non-profit entity but is funded by a commercial sponsor The next check is if the study involves human subjects (the IU-CTO only does contracts for Human Subjects Clinical Trials) The following checks involves the design of the clinical trial and the payment structure. We are looking for prospective clinical trials that are interventional, observational, or epidemiological A way to think about study design is ex-vivo versus in-vivo

Kuali Coeus Proposal Supplemental Guidance: Agreement Types that must be routed to CTO through Kuali Coeus Proposal: Clinical Trial Agreement Clinical Trial Agreement Amendment Subcontract Agreement ***All other agreement types (CDAs, SSUAs, FUA, etc.) must be sent to CTO Inbox*** AT (cto@iu.edu)

Clinical Trial Agreement Proposal: Must include: Final Version of the Study Protocol Draft Budget Internal Budget Draft Clinical Trial Agreement Clinical Trial Agreement Amendment Proposal: Draft Budget (if supplemental funds associated with amendment) Internal Budget (if supplemental funds associated with amendment) Subcontract Agreement Proposal: Scope of work Appropriate contact information for the Sub-Site

IU-CTO - Reminders The Conflict of Interest (COI) forms must be renewed after August 15, 2016.  Investigators will be required to complete a current form to ensure compliance with this annual requirement.  The COI form can be found at the following website: http://researchcompliance.iu.edu/coi/coi_disclosure.html) Visit the IU-CTO Process Map: (https://indianaclinicaltrialsoffice.iu.edu/investigators-study-coordinators/about-process-map/) Please note: the IU-CTO always strive for the Contract Negotiation, Budget Negotiation, IRB Submission, and OnCore Entry to occur simultaneously Always remember to contact the IU-CTO at CTO@IU.EDU with any questions!!! Our office is always happy to assist!